NewLink Genetics Corporation is a biopharmaceutical company focused on discovering developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians.


Updates from The Motley Fool

Latest updates on NewLink Genetics from Fool.com.
3 Biotechs Bucking the Downtrend

Mr. Market savaged the biotech sector yesterday. Specifically, 92% of small-caps were losers, 94%...

This Week in Biotech

With the  SPDR S&P Biotech Index  up 38% over the trailing-12-month period, it's evident that inv...



Stock Performance

View Interactive NLNK Charts
Sponsored by

Key Data Points

Primary metrics and data points about NewLink Genetics.
Current Price: $11.04
Prev Close: $11.27
Open: $11.09
Bid: $10.25
Ask: $16.00
Day's Range: $10.32 - $11.11
52wk Range: $9.23 - $37.65
Volume: 343,873
Avg Vol 248,867
Market Cap: $318M
P/E (ttm): -3.49
EPS (ttm): ($3.23)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about NewLink Genetics.
CAPS Rating 2 out of 5
 
45 Outperform
13 Underperform
CAPS All Stars
 
8 Outperform
5 Underperform

How do you think NewLink Genetics will perform against the market?



You pick for NewLink Genetics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Dr. Charles J. Link, CEO

25% Approve

Based on 4 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for NewLink Genetics.

NewLink Genetics Corporation is a biopharmaceutical company focused on discovering developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers